2010
DOI: 10.1016/j.peptides.2010.06.010
|View full text |Cite
|
Sign up to set email alerts
|

In vitro bactericidal activity of human β-defensin 2 against nosocomial strains

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
31
0
5

Year Published

2011
2011
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 50 publications
(37 citation statements)
references
References 36 publications
1
31
0
5
Order By: Relevance
“…One such mechanism involves antimicrobial peptide production (e.g., ␤-defensin 2 [BD2]). 〉D2 has been reported to exhibit strong bactericidal activity even against multidrug-resistant A. baumannii (31). Moreover, A. baumannii infection has been shown to upregulate ␤-defensin 2 levels in airway epithelial cells (8), but the underlying mechanism/signaling pathway is not yet known.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…One such mechanism involves antimicrobial peptide production (e.g., ␤-defensin 2 [BD2]). 〉D2 has been reported to exhibit strong bactericidal activity even against multidrug-resistant A. baumannii (31). Moreover, A. baumannii infection has been shown to upregulate ␤-defensin 2 levels in airway epithelial cells (8), but the underlying mechanism/signaling pathway is not yet known.…”
Section: Resultsmentioning
confidence: 99%
“…A. baumannii is no exception. Previous reports have shown that BD2 is highly effective in killing A. baumannii, including multidrug-resistant strains (31). In addition, A. baumannii is known to upregulate beta defensin 2 levels in airway epithelial cells, although the signaling pathways involved in this process are not well defined (8).…”
Section: Discussionmentioning
confidence: 99%
“…Our results demonstrated that hBD-2 induces selective accumulation of purine nucleosides, including Ado, which is an important and wellstudied immunomodulator, validating our initial hypothesis. The experimental setup was designed by considering the effective concentrations reported for hBD-2, ranging from 10 to 50 g/ml (24)(25)(26). In a physiologic context, the precise local concentrations of peptide at the site of defensin action are not known, and it is reported that most of the antimicrobial activity secreted by the intestinal mucosa is retained in the mucus layer, contributing to uneven distribution and variable local concentrations (27).…”
Section: Discussionmentioning
confidence: 99%
“…22 Patients with 25(OH) D levels less than 20 ng/mL may be unable to fully express cathelicidin, 18 which could be associated with increased susceptibility to nosocomial infections such as pneumonia, sepsis and central line infections. 21 Another antimicrobial peptide, human beta-defensin-2 (HBD)-2, may have special utility in multidrug resistant microbes from in vitro studies, 27 although its overall role is less clearly defined. In lesions observed in psoriasis and atopic dermatitis, vitamin D promoted increased cathelicidin 28 but decreased beta-defensin-2 production.…”
Section: Antimicrobial Efficacy Against Different Infective Agentsmentioning
confidence: 99%